Predictive Oncology Inc
NASDAQ:POAI
Predictive Oncology Inc
NASDAQ:POAI
Price:
5.48
USD
0.92%
Market Cap:
$18.6m
Relative Value
The Relative Value of one
POAI
stock under the Base Case scenario is
7.1
USD.
Compared to the current market price of 5.48 USD,
Predictive Oncology Inc
is
Undervalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
POAI
Relative Value
Base Case
7.1
USD
Undervaluation 23%
Multiples Across Competitors
POAI Competitors Multiples
Predictive Oncology Inc Competitors
Predictive Oncology Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Predictive Oncology Inc
NASDAQ:POAI
|
18.6m USD | 25.5 | -0.2 | -1.8 | -1.8 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.6T JPY | 10.5 | 38.4 | 27.8 | 33.4 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.3B CHF | 3.9 | 38 | 15.7 | 30.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
110.7B DKK | 3.9 | 27.2 | 14.2 | 16.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
14.2B USD | 3.5 | 34.8 | 18.6 | 24.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.4 | 13 | 21.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.7 | 19.6 | 92.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.5B CNY | 9.1 | 25.2 | 22.7 | 22.7 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.2 | 21.2 | 13.8 | 18.7 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.8B USD | 3.2 | 40.4 | 18.4 | 30.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
